Classifying the estrogen receptor status of breast cancers by expression profiles reveals a poor prognosis subpopulation exhibiting high expression of the ERBB2 receptor.
暂无分享,去创建一个
Vladimir B Bajic | Lee Chee How | V. Bajic | P. Tan | A. Aggarwal | Amit Aggarwal | Patrick Tan | Yu Kun | Tan Puay Hoon | Tan Sin Lam | Hong Ga Sze | Wee Siew Bok | Wong Chow Yin | L. How | T. Hoon | Yu Kun | T. Lam
[1] Vladimir B. Bajic,et al. Dragon ERE Finder version 2: a tool for accurate detection and analysis of estrogen response elements in vertebrate genomes , 2003, Nucleic Acids Res..
[2] Vladimir B. Bajic,et al. FIE2: a program for the extraction of genomic DNA sequences around the start and translation initiation site of human genes , 2003, Nucleic Acids Res..
[3] A. Wellstein,et al. Heregulin-β1 regulates the estrogen receptor-α gene expression and activity via the ErbB2/PI 3-K/Akt pathway , 2003, Oncogene.
[4] Isaac S Kohane,et al. Expression profiling reveals altered satellite cell numbers and glycolytic enzyme transcription in nemaline myopathy muscle , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[5] Mikael Lundin,et al. Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population-based study. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[6] S. Falkow,et al. Distinct gene expression profiles characterize the histopathological stages of disease in Helicobacter-induced mucosa-associated lymphoid tissue lymphoma , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[7] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[8] T. Poggio,et al. Multiclass cancer diagnosis using tumor gene expression signatures , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[9] H. Kurokawa,et al. Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[10] R. Spang,et al. Predicting the clinical status of human breast cancer by using gene expression profiles , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[11] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[12] Carsten O. Peterson,et al. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. , 2001, Cancer research.
[13] A. Ullrich,et al. Molecular targets for breast cancer therapy and prevention , 2001, Nature Medicine.
[14] Christine Brun,et al. In silico prediction of protein-protein interactions in human macrophages , 2001, BMC Research Notes.
[15] M. Macleod,et al. Effects of estrogen on global gene expression: identification of novel targets of estrogen action. , 2000, Cancer research.
[16] N. Sampas,et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.
[17] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[18] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[19] S. Sheng,et al. Classification of Breast Cancer Cells on the Basis of a Functional Assay for Estrogen Receptor , 1998, Molecular medicine.
[20] R. Lupu,et al. Bidirectional interactions between the estrogen receptor and the c‐erbB‐2 signaling pathways: Heregulin inhibits estrogenic effects in breast cancer cells , 1995, International journal of cancer.
[21] M. Sliwkowski,et al. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. , 1995, Oncogene.
[22] J Piper,et al. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[23] N. Day,et al. Cancer incidence in Singapore 1968-1977. , 1984, IARC scientific publications.
[24] C. Muir,et al. Cancer incidence in Singapore , 1967 .
[25] E. Robecchi. [Pathology of the breast]. , 1954, Minerva ginecologica.
[26] A. Wellstein,et al. Heregulin-beta1 regulates the estrogen receptor-alpha gene expression and activity via the ErbB2/PI 3-K/Akt pathway. , 2005, Oncogene.
[27] Vladimir B. Bajic,et al. Information and sequence extraction around the 5'-end and translation initiation site of human genes , 2002, Silico Biol..
[28] Sandip K. Mishra,et al. Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor , 2000, Nature Cell Biology.
[29] Vladimir Vapnik,et al. Statistical learning theory , 1998 .
[30] Gapped BLAST and PSI-BLAST: A new , 1997 .